Article
Establishment and validation of an immune-based prognostic score model in glioblastoma.
International immunopharmacology - 1 Aug 2020
Qin Zhigang, Zhang Xiuli, Chen Zhuo, Liu Naijie
Abstract excerpt
BACKGROUND: Immune escape is one of the landmark features of glioblastoma (GBM). Immunotherapy is undoubtedly a revolution in the field of tumor treatment, especially the application of immune checkpoint inhibitors and CAR-T cells, which have achieved amazing results in fighting against cancer. This study aimed to establish a TP53-related immune-based score model to improve the prognostic of GBM by investigating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
